Induced pluripotent stem cells (iPSCs) have been generated from somatic cells by transgenic expression of Oct4 (Pou5f1), Sox2, Klf4 and Myc. A major difficulty in the application of this technology for regenerative medicine, however, is the delivery of reprogramming factors. Whereas retroviral transduction increases the risk of tumorigenicity, transient expression methods have considerably lower reprogramming efficiencies. Here we describe an efficient piggyBac transposon-based approach to generate integration-free iPSCs. Transposons carrying 2A peptide-linked reprogramming factors induced reprogramming of mouse embryonic fibroblasts with equivalent efficiencies to retroviral transduction. We removed transposons from these primary iPSCs by re-expressing transposase. Transgene-free iPSCs could be identified by negative selection. piggyBac excised without a footprint, leaving the iPSC genome without any genetic alteration. iPSCs fulfilled all criteria of pluripotency, such as pluripotency gene expression, teratoma formation and contribution to chimeras. piggyBac transposon-based reprogramming may be used to generate therapeutically applicable iPSCs. We thank R. Banerjee for karyotype analysis, M. Li, C. Kokubu and K. Horie for help, suggestions and comments, and members of Team 82 and the Research Published online at http://www.nature.com/naturemethods/ Reprints and permissions information is available online at http://npg.nature.com/reprintsandpermissions/
Reprogramming of differentiated somatic cells into a pluripotent state has been carried out by cell fusion or nuclear transfer 1 . The molecular basis of reprogramming has been revealed by exogenous expression of combinations of transcription factors. Four factors, namely Oct4 (also known as Pou5f1), Sox2, Klf4 and Myc, that are important for self-renewal of embryonic stem cells (ESCs) have been shown to reprogram both mouse and human somatic cells into ESC-like pluripotent cells, named induced pluripotent stem cells (iPSCs) [2] [3] [4] . Induction of reprogramming by these defined four factors is mostly carried out by co-infection with retroviral vectors [2] [3] [4] . The main problems of this retrovirus-based method are oncogenicity and mutagenesis. Chimeric mice derived from iPSCs as well as their offspring developed tumors, probably because of reactivation of the proviral Myc oncogene 5 . Even though three-factor (Oct4, Sox2 and Klf4) iPSC-derived mice did not develop tumors 6 , ectopic expression of any one of these genes may have deleterious consequences. For instance, ectopic expression of Oct4 in skin and intestine causes tumor development 7 . Overexpression of Klf4 induces dysplasia in skin 8 . Furthermore, retroviral integration itself causes insertional mutagenesis and also may alter the expression pattern of nearby genes 9 . Transgene integration-free iPSCs are necessary for their future therapeutic application. To address this, two methods, namely adenoviral transduction 10 and repeated plasmid transfection 11 , have been recently reported. Both methods have been used to generate integration-free iPSCs. However, the reprogramming efficiencies of these methods were 100-1,000fold lower than those achieved by the retroviral method 10, 11 . New strategies to generate transgene-free iPSCs with a reasonable efficiency are required.
To achieve this, we used the piggyBac transposon system to deliver the reprogramming factors, which were linked by selfcleaving peptides. The approximately 20-amino acid 2A peptides from foot-and-mouth disease virus (F2A) and Thosea asigna virus (T2A) work as self-cleaving signals and enable expression of several gene products from a single transcript 12 , facilitating multigene delivery to target cells. The piggyBac transposon is a moth-derived DNA transposon 13 , which is highly active in mammalian cells and mice 14 , and has been used for gene delivery and mutagenesis 14 . The piggyBac transposon system has a very large cargo capacity: up to 10-kilobase DNA fragments can be transposed without losing transposition efficiency 14 . Unlike most other DNA transposons, piggyBac does not leave 'footprint' mutations upon excision 15 . For instance, the TA dinucleotides used by the Sleeping Beauty transposon as integration sites are changed to TAG(T/A)CTA after excision 16 . In contrast, the TTAA integration sites used by piggyBac transposons are repaired to the original sequence upon excision 15 . This allows removal of transposons from the host genome without changing any nucleotide sequence. Using the piggyBac transposon system, we generated transgene integration-free and mutation-free iPSCs, which are invaluable for therapeutic applications.
RESULTS

Construction of transposon-based reprogramming vectors
To deliver the reprogramming factors to recipient cells, we constructed piggyBac transposon-based reprogramming vectors ( Fig. 1a) . cDNAs constituting the open reading frames from Oct4, constructed a five-factor vector by linking Lin28 cDNA to the four-factor cassette (OSKM) through the sequence encoding the 2A peptide (designated OSKM). A pu∆tk cassette served as a negative selection marker for later transposon removal. These expression cassettes together with pu∆tk were flanked by the terminal repeats of the piggyBac transposon. To verify expression of each factor, we transfected 293T cells with the transposon vectors and analyzed protein expression by western blots (Fig. 1b) . Myc encoded by the four-factor vector and Lin28 encoded by the five-factor vector were detected migrating at the same molecular weights as their endogenous Sox2, Klf4 and Myc were combined into a single open reading frame separated by sequences encoding 2A peptides (designated OSKM) and placed under the constitutively active CAG promoter. We reasoned that Lin28 may enhance reprogramming because it is an essential factor for another reprogramming cocktail consisting of Oct4, Sox2, Nanog and Lin28 (ref. 4 ). Therefore we also 
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grew them in serum-based ESC medium (F15L) with or without valproic acid (VPA) for 5 d. On day 7, we changed the medium to serum-free ESC medium (K15L). The serum-free culture had been previously shown to enhance reprogramming of both mouse and human fibroblasts 17, 18 . We found that appropriate combinations of serum-based and serumfree media could enhance reprogramming and maximize the number of iPSC colonies compared to culture in either medium alone ( Supplementary Fig. 2 online) . Under these conditions, colonies became visible around day 7 without VPA and day 10 with VPA. At day 14, colonies were sufficiently large to be picked. Although VPA had been previously reported to enhance reprogramming efficiency of mouse and human fibroblasts 17, 19 , we did not observe this effect (Fig. 2b) . The striking effect of the addition of VPA was growth suppression of un-reprogrammed cells. Colonies without VPA treatment tended to be much bigger than VPA-treated colonies, and their morphology was not typical for ESC colonies, although all of these colonies were positive for alkaline phosphatase staining (Fig. 2b,c) . In contrast, VPA-treated colonies were more spherical and morphologically indistinguishable from ESC colonies ( Fig. 2c) . All ESC-like colonies were positive for Nanog expression as well as alkaline phosphatase staining ( Fig. 2c,d) , indicating successful counterparts. All other proteins were detected at slightly higher molecular weights because of the residual 2A peptides, which were still attached to their C termini ( Supplementary Fig. 1 online). Most antibodies also detected uncleaved proteins, but the amounts were far less than those of correctly processed proteins. These results indicate that 2A peptide-mediated cleavage of a single polypeptide chain efficiently produced individual reprogramming factors.
Generation of primary iPSCs using the transposon vector
We next investigated whether piggyBac transposons carrying the four or five factors could induce reprogramming in mouse embryonic fibroblasts (MEFs). The protocol we used is illustrated in Figure 2a . We performed cationic lipofection to introduce 2 µg of piggyBac transposon and 2 µg of piggyBac transposase expression vector into MEFs in six-well plates. One day after transfection, we replated MEFs onto a feeder layer at a split ratio of 1:18 and 
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imately twofold compared to the four-factor transposon ( Fig.  2e) . We transfected 10 6 MEFs with a transfection efficiency of approximately 10% and obtained approximately 1,000 colonies; therefore, the overall reprogramming efficiency was approximately 1%, virtually equivalent to the retroviral method. When we reduced the transposon amount from 2 µg to 0.5 µg, the colony number decreased about tenfold ( Fig. 2e) .
We picked colonies from the VPA-treated culture and established 'primary' iPSC lines, which were morphologically indistinguishable from ESCs and positive for endogenous Nanog expression ( Supplementary Fig. 3a online) . The efficiency of establishment of primary iPSCs was routinely more than 90%. We investigated the copy number of the integrated transposons by Southern blot analysis ( Supplementary Fig. 3c ). Using 2 µg of transposon DNA for the analysis, most colonies had multiple insertions. Twenty percent of colonies had two-copy integrations, which increased to 45% when we reduced the transposon DNA amount to 0.25 µg ( Fig. 2f) . We obtained only 1 colony with a single-copy integration in the 0.25 µg transfection, out of over 100 colonies analyzed, suggesting that at least two transposons are necessary for efficient reprogramming using our vectors. This may be explained by recent evidence suggesting that fibroblasts require higher expression of reprogramming factors than other cell types such as hepatocytes or epithelial cells 20 .
Removal of transposons from primary iPSCs
Next we attempted to eliminate transposons from the iPSC genome. Once excised, only 50% of transposons re-integrate into the genome 21 . We used the human herpes virus thymidine kinase (HSV tk)fialuridine (FIAU) selection system to select transposon-free iPSCs after transfection of piggyBac transposase-expressing plasmid ( Figs. 1a and 3a) . We used three independent primary iPSC clones (designated as iPS25, iPS28 and iPS216), which we confirmed to each carry two copies of the piggyBac transposon ( Fig. 3b and Supplementary Fig. 3d ). We used splinkerette PCR to identify the integration sites ( Supplementary Fig. 4 online).
After transient transposase expression and FIAU selection, we picked resistant colonies and screened them by PCR using transgene-specific primer pairs. We obtained 4 transposon-free clones out of 5 FIAU-resistant colonies from the iPS25 line, 7 clones out of 7 from iPS28 and 2 clones out of 11 from iPS216. In these reprogramming of these colonies. Notably, Nanog immunostaining showed that non-ESC-like colonies without VPA treatment contained many Nanog-positive patches (Fig. 2d) . All colonies grown without VPA contained at least one Nanog-positive small subcolony, indicating that reprogramming did occur, but that surrounding un-reprogrammed cells prevented reprogrammed cells from expanding and forming ESC-like colonies. Thus, VPA seems to suppress un-reprogrammed cell growth and facilitates expansion of reprogrammed cells to form colonies. Using the five-factor transposon, we increased the colony number approx- 
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lyzed their contribution to chimera development ( Fig. 5 and Supplementary Table 1 online). We therefore transfected the iPS25∆1 line with a constitutive enhanced (e)GFP expression vector. We identified chimeric embryos expressing eGFP at day 10.5 post coitum (d.p.c.) (Fig. 5a) . We obtained a live-born chimeric mouse expressing eGFP (Fig. 5b) . To determine whether integration-free iPSCs can contribute to the germ cell lineage, we targeted an eGFP cassette into the Nanog locus in the integrationfree iPSC line iPS25∆1 (Supplementary Fig. 9 online) . We dissected chimeric embryos at 12.5 d.p.c. and observed developing gonads under the fluorescence stereomicroscope. At this stage of development, Nanog is expressed exclusively in the germ cell lineage. Out of 7 embryos analyzed, 1 embryo had green fluorescent cells in the developing gonad, indicating that integration-free iPSCs contributed to the germ cell lineage (Fig. 5c) . We also obtained live-born chimeras from Nanog knock-in iPSCs ( Supplementary Table 1 ). Although germ line transmission in adult chimeras remains to be analyzed, we concluded that these iPSCs are genuinely pluripotent. Hence, transposon-based reprogramming generates transgene integration-free iPSCs.
dISCUSSIon
The major problem with reprogramming by transient expression systems, such as adenoviral transduction 10 and repeated plasmid transfection 11 , is the reduction in reprogramming factor expression over a few days as the cells divide. The doxycycline-inducible reprogramming system revealed that at least 10 d of stable expression is required to achieve reprogramming of both mouse and human fibroblasts [22] [23] [24] [25] , and that expression for more than 10 d increased the reprogramming efficiency [22] [23] [24] [25] . These results suggest that sustained expression of the factors is beneficial to achieve reprogramming with a higher efficiency. Our piggyBac transposon-based approach meets the criteria of high-efficiency reprogramming while retaining a nonmutated genome. This enabled us not only to reprogram somatic cells with efficiencies experiments the efficiency of transposon removal per transfected cell was approximately 10 −5 . However, FIAU selection allowed easy identification of integration-free iPSCs, as 50% of FIAU-resistant colonies were integration-free. We then expanded transposon-free clones (designated as ∆) and analyzed them by Southern blot for the 5′ repeat of the piggyBac transposon. For all clones that we identified to be transposon-free by PCR, Southern blot analysis confirmed the loss of their transposons (Fig. 3b) .
We also confirmed transposon removal using additional transgene probes (Supplementary Fig. 5 online) . To verify this, we performed genomic PCR in 2 clones from each parental primary iPSC line using a transposon-specific primer and primers specific for each integration site (Supplementary Fig. 4) . In all parental iPSC lines, specific host-transposon junction amplifications were readily detected, whereas MEFs and transposon-free iPSCs did not yield any PCR products ( Fig. 3c-e ). We confirmed this by using primer pairs specific for the transposon ( Supplementary  Fig. 6 online) . Furthermore, exhaustive PCR analyses did not show any random integration of the transposon vector or the piggyBac transposase expression vector (Supplementary Fig. 6 ).
Thus, we conclude that the transposons had been successfully removed in FIAU-resistant iPSC colonies.
The piggyBac transposon does not leave a footprint at the excised site. To confirm that the transgene-free iPSC had no footprint mutations, we PCR-amplified the genomic regions encompassing the integration-excision sites and sequenced the PCR products directly. If there was a footprint mutation (for instance, a nucleotide change, insertion or deletion), the sequence after TTAA, the target site of piggyBac integration, would be a mixture of sequences from the wild-type allele and the excised allele. The signals from all integration sites were identical to the original genomic sequence (Fig. 3f,g and Supplementary Fig. 7 online) , indicating the absence of footprint mutations. Thus, we 'cured' transgene-harboring iPSCs by removing the transposon.
Pluripotency of the integration-free iPSCs
The integration-free iPSCs had a normal karyotype (Fig. 4a) . To investigate whether these transposon-free iPSCs are pluripotent, we first conducted reverse-transcription PCR (RT-PCR) analysis of 7 ESC-specific genes (Oct4, Sox2, Nanog, Ecat1 (also known as 2410004A20Rik), Esrrb, Dppa3 and Dnmt3l) ( Fig. 4b and Supplementary Fig. 8 online) . All genes analyzed were expressed in iPSCs at similar levels to ESCs. Immunofluorescence staining also showed that iPSC lines uniformly expressed Oct4 and Nanog (Fig. 4c) . To analyze reprogramming, we investigated the DNA methylation status at the Oct4 and Nanog promoter regions by bisulphite sequencing. Consistent with previous reports, these promoter regions were hypermethylated in MEFs and hypomethylated in ESCs (Fig. 4d) . In the transgene-free iPSCs, these promoter regions were also demethylated ( Fig. 4d) , indicating that iPSCs were epigenetically reprogrammed. To investigate whether transgene-free iPSCs are pluripotent, we performed in vivo differentiation analysis. Pluripotent cells form teratomas when injected subcutaneously into immunodeficient mice. Four weeks after injection, integration-free iPSCs gave rise to teratomas. Histological analysis of the teratomas showed that they contained endodermal (epithelial tissue), mesodermal (muscle and cartilage) and ectodermal (epidermis) tissues (Fig. 4e) . To further test the pluripotency of integration-free iPSCs, we ana- 30 . The use of the 2A peptide provides an easy way to link even more than five factors in a single expression cassette. The piggyBac transposon serves as a versatile vehicle for such large and complex cargoes, as the transposition efficiency is not limited by its cargo size.
One of the most important results of our approach is the direct selection of integration-free iPSCs. By titrating the transposon DNA amount, we established a condition in which about half of the primary iPSC colonies have two or fewer transposon copies. As an alternative to the clone-based approach used here, the primary iPSC colonies can be pooled together for downstream transposon removal (Fig. 6) . We also isolated transposon-free iPSCs using FIAU selection for the loss of pu∆tk from a primary iPSC pool (data not shown). This simple and rapid approach will be invaluable for the generation of patient-specific integration-free iPSCs.
While this manuscript was under review, two groups reported similar results 31, 32 . These groups used 2A peptides to link the four factors, delivered them using the piggyBac transposon and reprogrammed mouse and human fibroblasts. However, in their work, the recovery of transgene-free iPSCs was not facilitated by selection. The negative selection system incorporated in our vectors enables efficient isolation of transgene-free iPSCs.
The piggyBac transposon-based method together with the polycistronic expression design offers an alternative strategy for the efficient generation of iPSCs with an intact genome. We envision that this strategy will facilitate the generation of patient-specific iPSCs for drug discovery and cell-based regenerative medicine.
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/.
Note: Supplementary information is available on the Nature Methods website. similar to the retroviral method but also to remove the reprogramming factors from the iPSCs permanently without genetic alteration.
Genomic integrity is key for therapeutic applications of iPSCs. However, it has been shown that approximately 5% of piggyBac excisions in mouse ESCs had microdeletions at the excision sites 21 , which might be mutagenic. Also, donor cells used for the generation of iPSCs can in principle have already acquired somatic mutations. Genetic alterations could also occur during the reprogramming process. Whole-genome sequencing methods could be used to identify these mutations and the most suitable iPSC line for therapeutic applications.
Notably, it seems that piggyBac transposition does not require host factors 26 . Our method could be readily applied to other cell types such as keratinocytes, which can be reprogrammed more efficiently than fibroblasts 27 to generate integration-free iPSCs.
We observed significant reduction in iPSC colony formation upon VPA treatment ( Fig. 2e) , although VPA treatment generated more homogeneous iPSC colonies. VPA had been previously reported to enhance reprogramming efficiency when retroviral methods had been used 17, 19 . It is likely that VPA opens chromatin, as genes whose expression is elevated in ESCs compared to MEF, are upregulated after 7 d treatment in MEFs 19 . If this is the case, VPA treatment can be beneficial for cells which do not receive all factors or only receive low copy numbers of individual reprogramming factors and therefore have insufficient expression of these factors. As polycistronic expression from a strong promoter provides sufficient expression of all reprogramming factors, enhancement by VPA could not be observed. Rather, we saw a reduction of overall reprogramming efficiency. This could be due to a growth-suppressive effect of VPA on certain MEF subpopulations. We indeed observed that after VPA treatment growth of MEFs was negatively affected (data not shown).
We used 2A peptides for the polycistronic expression of the reprogramming factors from a single vector. This strategy has been used in recent studies and proven to be capable of generating iPSCs 11, 28 . In our study, we combined the five known reprogramming factors (Oct4, Sox2, Klf4, Myc and Lin28) into a single vector and induced reprogramming of MEFs more efficiently than with the four-factor vector. The use of additional factors in combination with the five factors might enhance the reprogramming efficiency. UTF1 expression or TP53 knockdown, for example, have been recently reported to substantially enhance reprogramming of human fibroblasts 29 . It was also shown that either ectopic expression of C/EBPα or Pax5 knockdown was required piggyBac transposon-based expression vector was constructed as follows. First, a CAG promoter-driven expression vector, pCAG. EBNXN, was generated by replacing the Eco RI-Nsi I fragment of pCAG-IP 33 with a linker containing multicloning sites (Eco RI, Bgl II, Not I, Xho I and Nsi I). Second, a piggyBac vector carrying a CAG promoter-driven expression cassette, pPB-CAG.EBNXN, was generated by inserting the Sal I-Bam HI fragment of pCAG.EBNXN into the Xho I-Bam HI site of pPB-LR 34 . Four-factor or five-factor expression vectors were constructed as follows. Four-or five-factor expression vectors were constructed by inserting the Bam HI-Sal I fragment of the four-factor construct or the Bam HI-Xho I fragment of the five-factor construct into the Bgl II-Xho I site of pPB-CAG. EBNXN, resulting in pPB-CAG.4F, pPB-CAG.4FT, pPB-CAG.4FTT and pPB-CAG.4FTTL, respectively. Finally, a negative selection marker, PGK-pu∆tk cassette, was excised from pFlexible by Xho I digestion and inserted into the Sal I site of pPB-CAG-based factor expression vectors.
piggyBac transposon vector with an eGFP cassette was constructed as follows. First, a piggyBac transposon vector carrying the human ubiquitin C (UbC) promoter-driven expression cassette was constructed. UbC promoter and bovine growth hormone polyadenylation signal sequence (bpA) were PCR amplified with a primer pair of UbC-U and UbC-L and bpA-U and bpA-L, respectively. An Nhe I -Eco RI fragment of UbC promoter and an Eco RI-Sal I fragment of bpA were ligated into the Nhe I-Sal I site of pPB-LR, resulting in pPB-UbC. Second, an eGFP fragment was excised from pCX-GFP and inserted into the Eco RI site of pPB-UbC, resulting in pPB-UbC. eGFP. Finally, PGKneo cassette was excised from PL452 (ref. 35) by Xho I digestion and inserted into the Sal I site of pPB-UbC.eGFP, resulting in pPB-UbC.eGFP-neo.
Cell culture. MEFs were prepared from 14.5 d.p.c. wild-type embryos (inbred C57Bl/6-Tyr c-Brd/c-Brd for the piggyBac study, and B6129S6F1 and ICRB6F1 for the retroviral study) and cultured in DMEM containing 10% fetal bovine serum (FBS; HyClone), 2 mM l-glutamine, 1× nonessential amino acids (Invitrogen), and 0.1 mM 2-mercaptoethanol. A germline-competent mouse ESC line (KY1.1, B6129S6F1 background; unpublished data) and mouse iPSC lines were cultured on mitomycin C-treated MEFs in serum-containing ESC medium (F15L), which is DMEM with 15% FBS, 2 mM l-glutamine, 1× nonessential amino acids, 0.1 mM 2-mercaptoethanol and 1,000 U ml -1 Leukemia inhibitory factor (LIF; Chemicon). The 293T cells were cultured in DMEM containing 10 % FBS and 2 mM l-glutamine.
Reprogramming of MEFs using transposon vectors.
MEFs were plated onto six-well plates (5 × 10 5 cells per well) 1 d before transfection. The next day (day 0), 2 µg of pCMV-mPBase 34 and various amounts of plasmids containing the piggyBac transposon were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. On day 1, transfected MEFs were trypsinised and replated onto feeder layers at a split ratio of 1:18 in MEF medium. On day 2, F15L medium was applied. VPA was added to culture medium at 2 mM 19 from day 2 to day 7. The medium was refreshed every other day. On day 7, medium was changed to serumfree ESC medium (K15L), which contains 15% Knockout serum replacement (Invitrogen) instead of FBS. Medium was refreshed every other day. On day 14, colonies were either stained using the alkaline phosphatase detection kit (Chemicon) and counted, or picked and further expanded.
Reprogramming of MEFs by retroviral vectors.
Retroviral vectors (pMXs-Oct3/4, pMXs-Sox2, pMXs-Klf4, pMXs-c-Myc) 2 were obtained from Addgene. Preparation of retroviruses and infection of MEFs was described in reference 2. One day after infection cells were replated onto six-well plates containing a feeder layer at 3,000 cells per well. Subsequent culture conditions are described in Supplementary  Figure 2 .
Transposon removal from primary iPSCs. The piggyBac transposaseexpression vector was electroporated into 2 × 10 6 iPSCs. Cells were maintained for 3 d to allow turnover of the pu∆tk protein. We then seeded 5 × 10 5 cells onto 10-cm dishes containing feeder cells. The next day FIAU was added to the culture medium (0.2 µM final concentration) and selection was continued for 5 d. After an additional 5 d of culture without FIAU, the resulting colonies were picked and expanded. Transposon removal was examined by PCR with primers listed in Supplementary Table 2 and confirmed by Southern blot analysis using the 5′ terminal repeat of the piggyBac transposon as a probe. The probe for the 5′ terminal repeat of piggyBac transposon specifically detects the 5′ repeat and does not detect the 3′ terminal repeat in the Southern blot analysis. eGFP marking of an integration-free iPSC line. A cured iPSC line iPS25∆1 was electroporated with 25 µg of a linearized Nanog-eGFP 2000 according to the manufacturer's instructions. Forty-eight hours after transfection, cells were collected and suspended in LDS sample buffer (Invitrogen) and proteins were separated on 4-15% gradient gels. Protein blots were analyzed using antibodies to Oct4 (mouse monoclonal, C-10; Santa Cruz), antibody to Sox2 (rabbit polyclonal, H-65; Santa Cruz), antibody to Klf4 (rabbit polyclonal, H-180; Santa Cruz), antibody to Myc (rabbit polyclonal, ab11917; Abcam), antibody to Lin28 (rabbit polyclonal, ab46020; Abcam) or antibody to β-actin (mouse monoclonal, AC-15; Sigma).
Immunostaining. Cells were fixed in 4% paraformaldehyde in PBS for 15 min at room temperature (18-22 °C) and permeabilized in 0.05% Triton-X100 in PBS for 10 min at room temperature, then blocked in 1% BSA in PBS for 1 h at room temperature. Cells were washed with PBS and incubated with antibody to Nanog (1:300, rabbit polyclonal; ab21603, Abcam) and/or antibody to Oct4 (1:50, mouse monoclonal, C-10; Santa Cruz) over night at 4 °C. After washing with PBS (6 × 10 min), cells were labeled with Alexa 488or Alexa 555-conjugated secondary antibodies (Invitrogen) for 1 h at room temperature. Cells were then washed with PBS (3 × 10 min) and nuclei were counterstained with Toto-3 at 0.5 µM in PBS for 1 h at room temperature. After final washing with PBS (3 × 10 min), specimens were analyzed using a fluorescence microscope or Radiance2000 confocal microscope (Bio-Rad). The Vectastain ABC kit (Vector laboratory) was used for chromogenic detection according to the manufacturer's instructions.
Teratoma formation and blastocyst injection. Approximately 1 × 10 6 integration-free iPSCs were injected subcutaneously into dorsal flanks of recipient severe combined immunodeficiency mice. Tumors were isolated 4 weeks later and subjected to histological analysis. eGFP-marked integration-free iPSCs were microinjected into C57Bl/6-Tyr c-Brd/c-Brd blastocysts and embryos were transplanted into CBA × B6F1 pseudopregnant females. In some experiments, embryos were dissected at the indicated time points and observed under the fluorescent stereomicroscope. Chimerism of newborn mice was analyzed by PCR of DNA extracted from tails with eGFP primers. All animal studies were carried out at the Wellcome Trust Sanger Institute under the UK Home Office license 80/2020.
